RxDoctor Payments Data

Craig McDaniel, MD

Family Medicine · Jonesboro, ARNPI 1912960519

Payments from drug & device makers

$6,828in general payments, 2019–2025

Across 408 payments — averaging $16.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$772
  • AbbVie$678
  • Pfizer$629
  • Johnson & Johnson$617
  • Takeda Pharmaceuticals U.S.A., Inc.$516
  • Otsuka America Pharmaceutical, Inc.$440
  • plus $3K from 39 others

What the payments were for

  • Food & beverage$6,828100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,828 in reported general payments places this provider in the 90th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$168,504
Medicare patients
577
Services billed
2,646

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban89$78,576
OzempicSemaglutide47$63,807
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$20,943
XareltoRivaroxaban27$20,322
MounjaroTirzepatide12$12,369
JardianceEmpagliflozin21$11,691
FarxigaDapagliflozin Propanediol14$9,918
Tresiba Flextouch U-100Insulin Degludec16$8,288
Lantus SolostarInsulin Glargine,hum.Rec.Anlog38$4,920
Pantoprazole Sodium477$4,735
Gabapentin328$4,368
Atorvastatin Calcium487$4,098
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog14$3,489
Alprazolam501$3,097
Potassium Chloride176$2,937

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$629$78,57689 claims
Novo NordiskOzempic$772$63,80747 claims
GSKTrelegy Ellipta$105$20,94322 claims
Johnson & JohnsonXarelto$617$20,32227 claims
Lilly USA, LLCMounjaro$121$12,36912 claims
Boehringer IngelheimJardiance$98$11,69121 claims
AstraZenecaFarxiga$219$9,91814 claims
Almatica Pharma LLCSertraline Hcl$41$1,299127 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Jonesboro

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →